Tavapadon (developmental code names CVL-751, PF-06649751) is a dopamine receptor agonist which is under development for the treatment of Parkinson's disease...
6 KB (410 words) - 02:00, 6 August 2024
Cerevel drugs and treatments at varying stages of development include: Tavapadon (Parkinson's) Emraclidine (Schizophrenia, Alzheimer's) Darigabat (Epilepsy)...
10 KB (802 words) - 16:07, 12 August 2024
6669571 Propylnorapomorphine Rotigotine SKF-89,145 SKF-89,626 Stepholidine Tavapadon Tetrahydropalmatine PAMs Tetrahydroisoquinolines: DETQ DPTQ Mevidalen...
118 KB (11,362 words) - 03:35, 26 August 2024
6669571 Propylnorapomorphine Rotigotine SKF-89,145 SKF-89,626 Stepholidine Tavapadon Tetrahydropalmatine PAMs Tetrahydroisoquinolines: DETQ DPTQ Mevidalen...
166 KB (16,734 words) - 20:53, 26 August 2024
2 clinical trials for dementia-related apathy. Mevidalen (LY-3154207) Tavapadon (CVL-751) "CVL 871 - AdisInsight". Hatzipantelis CJ, Langiu M, Vandekolk...
4 KB (214 words) - 00:46, 4 August 2024
6669571 Propylnorapomorphine Rotigotine SKF-89,145 SKF-89,626 Stepholidine Tavapadon Tetrahydropalmatine PAMs Tetrahydroisoquinolines: DETQ DPTQ Mevidalen...
21 KB (1,748 words) - 12:42, 5 August 2024
6669571 Propylnorapomorphine Rotigotine SKF-89,145 SKF-89,626 Stepholidine Tavapadon Tetrahydropalmatine PAMs Tetrahydroisoquinolines: DETQ DPTQ Mevidalen...
32 KB (2,680 words) - 07:25, 27 July 2024
6669571 Propylnorapomorphine Rotigotine SKF-89,145 SKF-89,626 Stepholidine Tavapadon Tetrahydropalmatine PAMs Tetrahydroisoquinolines: DETQ DPTQ Mevidalen...
130 KB (11,783 words) - 08:48, 16 August 2024
6669571 Propylnorapomorphine Rotigotine SKF-89,145 SKF-89,626 Stepholidine Tavapadon Tetrahydropalmatine PAMs Tetrahydroisoquinolines: DETQ DPTQ Mevidalen...
42 KB (3,639 words) - 01:52, 26 August 2024
6669571 Propylnorapomorphine Rotigotine SKF-89,145 SKF-89,626 Stepholidine Tavapadon Tetrahydropalmatine PAMs Tetrahydroisoquinolines: DETQ DPTQ Mevidalen...
31 KB (2,342 words) - 16:44, 31 July 2024